137 related articles for article (PubMed ID: 29797653)
1. Late mortality and morbidity among long-term leukemia survivors with Down syndrome: A nationwide population-based cohort study.
Vonasek J; Asdahl P; Heyman M; Källén K; Hasle H
Pediatr Blood Cancer; 2018 Sep; 65(9):e27249. PubMed ID: 29797653
[TBL] [Abstract][Full Text] [Related]
2. Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971-2008 in Denmark, Finland, and Sweden: A population-based cohort study.
Sørensen GV; Belmonte F; Erdmann F; Mogensen H; Albieri V; Holmqvist AS; Madanat-Harjuoja L; Talbäck M; Heyman MM; Malila N; Feychting M; Schmiegelow K; Winther JF; Hasle H
Pediatr Blood Cancer; 2022 Jan; 69(1):e29356. PubMed ID: 34582112
[TBL] [Abstract][Full Text] [Related]
3. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
Buitenkamp TD; Izraeli S; Zimmermann M; Forestier E; Heerema NA; van den Heuvel-Eibrink MM; Pieters R; Korbijn CM; Silverman LB; Schmiegelow K; Liang DC; Horibe K; Arico M; Biondi A; Basso G; Rabin KR; Schrappe M; Cario G; Mann G; Morak M; Panzer-Grümayer R; Mondelaers V; Lammens T; Cavé H; Stark B; Ganmore I; Moorman AV; Vora A; Hunger SP; Pui CH; Mullighan CG; Manabe A; Escherich G; Kowalczyk JR; Whitlock JA; Zwaan CM
Blood; 2014 Jan; 123(1):70-7. PubMed ID: 24222333
[TBL] [Abstract][Full Text] [Related]
4. Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample.
Ou JY; Smits-Seemann RR; Kaul S; Fluchel MN; Sweeney C; Kirchhoff AC
Cancer Epidemiol; 2017 Aug; 49():216-224. PubMed ID: 28734233
[TBL] [Abstract][Full Text] [Related]
5. Risks of late mortality and morbidity among survivors of childhood acute leukemia with Down syndrome: A population-based cohort study.
Gupta S; Sutradhar R; Pequeno P; Hitzler JK; Liu N; Nathan PC
Cancer; 2022 Mar; 128(6):1294-1301. PubMed ID: 34847248
[TBL] [Abstract][Full Text] [Related]
6. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
Goldsby RE; Stratton KL; Raber S; Ablin A; Strong LC; Oeffinger K; Sklar CA; Armstrong GT; Robison LL; Bhatia S; Leisenring WM
Cancer; 2018 Feb; 124(3):617-625. PubMed ID: 29105081
[TBL] [Abstract][Full Text] [Related]
7. Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington State.
Ording AG; Christensen LB; Bjørge T; Doody DR; Ekbom A; Glimelius I; Grotmol T; Larfors G; Mueller BA; Smedby KE; Tretli S; Troisi R; Sørensen HT
Acta Oncol; 2020 Aug; 59(8):949-958. PubMed ID: 32174251
[No Abstract] [Full Text] [Related]
8. Acute leukemias in children with Down syndrome.
Seewald L; Taub JW; Maloney KW; McCabe ER
Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
[TBL] [Abstract][Full Text] [Related]
9. [Acute leukemia in patients with Down syndrome].
Fernández-Plaza S; Sevilla J; Contra T; Martín N; Madero L
An Pediatr (Barc); 2004 Dec; 61(6):515-9. PubMed ID: 15574252
[TBL] [Abstract][Full Text] [Related]
10. Mortality and cancer incidence among individuals with Down syndrome.
Hill DA; Gridley G; Cnattingius S; Mellemkjaer L; Linet M; Adami HO; Olsen JH; Nyren O; Fraumeni JF
Arch Intern Med; 2003 Mar; 163(6):705-11. PubMed ID: 12639204
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.
Goto H; Kaneko T; Shioda Y; Kajiwara M; Sakashita K; Kitoh T; Hayakawa A; Miki M; Kato K; Ogawa A; Hashii Y; Inukai T; Kato C; Sakamaki H; Yabe H; Suzuki R; Kato K
Pediatr Blood Cancer; 2015 Jan; 62(1):148-52. PubMed ID: 25262825
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
[TBL] [Abstract][Full Text] [Related]
13. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
[TBL] [Abstract][Full Text] [Related]
14. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
[TBL] [Abstract][Full Text] [Related]
15. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
16. Child and adolescent Down syndrome-associated leukaemia: the Irish experience.
O'Rafferty C; Kelly J; Storey L; Ryan C; O'Marcaigh A; Smith O
Ir J Med Sci; 2015 Dec; 184(4):877-82. PubMed ID: 25344131
[TBL] [Abstract][Full Text] [Related]
17. Celiac disease and Down syndrome mortality: a nationwide cohort study.
Ludvigsson JF; Lebwohl B; Green PH; Chung WK; Mårild K
BMC Pediatr; 2017 Jan; 17(1):41. PubMed ID: 28143429
[TBL] [Abstract][Full Text] [Related]
18. Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome.
Athale U; Sutradhar R; Breakey VR; Li Q; Bassal M; Gibson P; Patel S; Wheaton L; Pole JD; Mittman N; Pechlivanoglou P; Gupta S
Pediatr Blood Cancer; 2022 Oct; 69(10):e29829. PubMed ID: 35674471
[TBL] [Abstract][Full Text] [Related]
19. Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors.
de Fine Licht S; Rugbjerg K; Gudmundsdottir T; Bonnesen TG; Asdahl PH; Holmqvist AS; Madanat-Harjuoja L; Tryggvadottir L; Wesenberg F; Hasle H; Winther JF; Olsen JH;
PLoS Med; 2017 May; 14(5):e1002296. PubMed ID: 28486495
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome for Down syndrome patients with hematopoietic disorders.
Li MJ; Lee NC; Yang YL; Yen HJ; Chang HH; Chien YH; Lu MY; Jou ST; Lin KH; Hwu WL; Lin DT
J Formos Med Assoc; 2016 Feb; 115(2):94-9. PubMed ID: 26234152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
